Search

Gerresheimer AG

Geschlossen

BrancheGesundheitswesen

28.98 3.87

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

28.72

Max

29.02

Schlüsselkennzahlen

By Trading Economics

Einkommen

35M

18M

Verkäufe

81M

601M

KGV

Branchendurchschnitt

40.059

37.461

EPS

0.69

Dividendenrendite

0.15

Gewinnspanne

2.934

Angestellte

13,535

EBITDA

35M

119M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+13.5% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.15%

2.33%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-772M

941M

Vorheriger Eröffnungskurs

25.11

Vorheriger Schlusskurs

28.98

Nachrichtenstimmung

By Acuity

50%

50%

147 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Gerresheimer AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Apr. 2025, 10:15 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4. Apr. 2025, 09:39 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

Gerresheimer AG Prognose

Kursziel

By TipRanks

13.5% Vorteil

12-Monats-Prognose

Durchschnitt 32.96 EUR  13.5%

Hoch 46 EUR

Tief 23 EUR

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Gerresheimer AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

10 ratings

3

Buy

5

Halten

2

Sell

Technischer Score

By Trading Central

60.1 / 60.95Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

147 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
help-icon Live chat